AnDC-0003

N/A

Report date: 2022/05/10 11:41:00

Base Information

Drug NameAnDC-0003
Drug Alias NameAnDC0003
ClassificationBiologics
Mechanisms of ActionUbiquitin-protein ligases inhibitors
TargetsUbiquitin-protein ligases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrum Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrum Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A